These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 37100061

  • 1. A Randomized, Controlled, Noninferiority, Multicenter Trial of Systemic vs Intralesional Treatment With Meglumine Antimoniate for Cutaneous Leishmaniasis in Brazil.
    Lyra MR, Oliveira LFA, Schubach AO, Sampaio RNR, Rodrigues BC, Hueb M, Cota G, Silva RE, Francesconi F, Pompilio MA, França AO, Amato VS, Souza RM, Oliveira RVC, Valete CM, Pimentel MIF.
    Clin Infect Dis; 2023 Aug 22; 77(4):574-582. PubMed ID: 37100061
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of intra-lesional injections of meglumine antimoniate once a week vs. twice a week in the treatment of cutaneous leishmaniasis caused by L. tropica in Iran: A randomized controlled clinical trial.
    Javadi A, Khamesipour A, Ghoorchi M, Bahrami M, Khatami A, Sharifi I, Eskandari SE, Fekri A, Aflatoonian MR, Firooz A.
    PLoS Negl Trop Dis; 2022 Jul 22; 16(7):e0010569. PubMed ID: 35802749
    [Abstract] [Full Text] [Related]

  • 3. An old drug and different ways to treat cutaneous leishmaniasis: Intralesional and intramuscular meglumine antimoniate in a reference center, Rio de Janeiro, Brazil.
    Oliveira-Ribeiro C, Pimentel MIF, Oliveira LFA, Vasconcellos ÉCFE, Conceição-Silva F, Schubach AO, Fagundes A, de Mello CX, Mouta-Confort E, Miranda LFC, Valete-Rosalino CM, Martins ACDC, Oliveira RVC, Quintella LP, Lyra MR.
    PLoS Negl Trop Dis; 2021 Sep 22; 15(9):e0009734. PubMed ID: 34555016
    [Abstract] [Full Text] [Related]

  • 4. Comparison between systemic and intralesional meglumine antimoniate therapy in a primary health care unit.
    de Oliveira Duque MC, Quintão Silva JJ, Soares PAO, Magalhães RS, Horta APA, Paes LRB, Rosandiski Lyra M, Pimentel MIF, de Fátima Antonio L, de Camargo Ferreira E Vasconcellos É, Saheki MN, de Almeida Marzochi MC, Valete-Rosalino CM, de Oliveira Schubach A.
    Acta Trop; 2019 May 22; 193():176-182. PubMed ID: 30851256
    [Abstract] [Full Text] [Related]

  • 5. Resolution of cutaneous leishmaniasis after acute eczema due to intralesional meglumine antimoniate.
    Ferreira e Vasconcellos Ede C, Pimentel MI, Valete-Rosalino CM, Madeira Mde F, Schubach Ade O.
    Rev Inst Med Trop Sao Paulo; 2014 May 22; 56(4):361-2. PubMed ID: 25076440
    [Abstract] [Full Text] [Related]

  • 6. Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial.
    Ramalho DB, Silva RED, Senna MCR, Moreira HSA, Pedras MJ, Avelar DM, Saraiva L, Rabello A, Cota G.
    Mem Inst Oswaldo Cruz; 2018 Jun 21; 113(9):e180200. PubMed ID: 29947651
    [Abstract] [Full Text] [Related]

  • 7. Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre.
    Silva RE, Toledo A, Senna MC, Rabello A, Cota G.
    Mem Inst Oswaldo Cruz; 2016 Aug 21; 111(8):512-6. PubMed ID: 27508321
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial.
    Romero GAS, Costa DL, Costa CHN, de Almeida RP, de Melo EV, de Carvalho SFG, Rabello A, de Carvalho AL, Sousa AQ, Leite RD, Lima SS, Amaral TA, Alves FP, Rode J, Collaborative LVBrasil Group.
    PLoS Negl Trop Dis; 2017 Jun 21; 11(6):e0005706. PubMed ID: 28662034
    [Abstract] [Full Text] [Related]

  • 9. Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.
    López L, Robayo M, Vargas M, Vélez ID.
    Trials; 2012 May 17; 13():58. PubMed ID: 22594858
    [Abstract] [Full Text] [Related]

  • 10. Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children.
    Rubiano LC, Miranda MC, Muvdi Arenas S, Montero LM, Rodríguez-Barraquer I, Garcerant D, Prager M, Osorio L, Rojas MX, Pérez M, Nicholls RS, Gore Saravia N.
    J Infect Dis; 2012 Feb 15; 205(4):684-92. PubMed ID: 22238470
    [Abstract] [Full Text] [Related]

  • 11. Intralesional infiltration versus parenteral use of meglumine antimoniate for treatment of cutaneous leishmaniasis: A cost-effectiveness analysis.
    Brito NC, Machado de Assis TS, Rabello A, Cota G.
    PLoS Negl Trop Dis; 2019 Dec 15; 13(12):e0007856. PubMed ID: 31805052
    [Abstract] [Full Text] [Related]

  • 12. Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006).
    Vasconcellos Ede C, Pimentel MI, Schubach Ade O, de Oliveira Rde V, Azeredo-Coutinho RB, Silva Fda C, Salgueiro Mde M, Moreira JS, Madeira Mde F, Baptista C, Valete-Rosalino CM.
    Am J Trop Med Hyg; 2012 Aug 15; 87(2):257-60. PubMed ID: 22855754
    [Abstract] [Full Text] [Related]

  • 13. American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment.
    Carvalho SH, Frézard F, Pereira NP, Moura AS, Ramos LMQC, Carvalho GB, Rocha MOC.
    Trop Med Int Health; 2019 Apr 15; 24(4):380-391. PubMed ID: 30681239
    [Abstract] [Full Text] [Related]

  • 14. A retrospective cohort study of the effectiveness and adverse events of intralesional pentavalent antimonials in the treatment of cutaneous leishmaniasis.
    Rodrigues BC, Ferreira MF, Barroso DH, Motta JOCD, Paula CDR, Porto C, Martins SS, Gomes CM, Sampaio RNR.
    Int J Parasitol Drugs Drug Resist; 2020 Dec 15; 14():257-263. PubMed ID: 33285343
    [Abstract] [Full Text] [Related]

  • 15. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
    Asilian A, Sadeghinia A, Faghihi G, Momeni A, Amini Harandi A.
    Ann Trop Med Parasitol; 2003 Jul 15; 97(5):493-8. PubMed ID: 12930612
    [Abstract] [Full Text] [Related]

  • 16. Comparison Of Efficacy Of Miltefosine Versus Meglumine Antimonate In The Treatment Of Cutaneous Leishmaniasis.
    Mohammad N, Sagheer F, Paracha MM, Khan AQ, Naseem S, Wasim M.
    J Ayub Med Coll Abbottabad; 2022 Jul 15; 34(4):849-853. PubMed ID: 36566412
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.
    Munir A, Janjua SA, Hussain I.
    Acta Dermatovenerol Croat; 2008 Jul 15; 16(2):60-4. PubMed ID: 18541100
    [Abstract] [Full Text] [Related]

  • 18. Comparison of Meglumine Antimoniate and Miltefosine in Cutaneous Leishmaniasis.
    Rahman A, Tahir M, Naveed T, Abdullah M, Qayyum N, Malik DH, Amin B.
    J Coll Physicians Surg Pak; 2023 Dec 15; 33(12):1367-1371. PubMed ID: 38062590
    [Abstract] [Full Text] [Related]

  • 19. Use of topical rSm29 in combination with intravenous meglumine antimoniate in the treatment of cutaneous leishmaniasis: A randomized controlled trial.
    Lago T, Peixoto F, Mambelli F, Carvalho LP, Guimarães LH, Carvalho AM, Cardoso L, Machado PRL, Scott P, Lago J, Andrade JM, Fahel JS, Oliveira SC, Carvalho EM.
    Int J Infect Dis; 2024 Oct 15; 147():107206. PubMed ID: 39147194
    [Abstract] [Full Text] [Related]

  • 20. Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013).
    Brahim LR, Valete-Rosalino CM, Antônio LF, Pimentel MIF, Lyra MR, Paes LEC, Costa ADD, Vieira IF, Dias CMG, Duque MCO, Marzochi MCA, Schubach AO.
    Mem Inst Oswaldo Cruz; 2017 Dec 15; 112(12):838-843. PubMed ID: 29211245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.